Daily Market Research Report

February 12, 2026

Alpha Signal Monitor

Welcome to your daily pre-market briefing. This report provides key insights on market opportunities and analyst perspectives to help identify potential alpha signals.

Today's Coverage: - Gold ETF Outlook: Institutional perspectives on gold-backed ETFs - Stock Ratings: Latest analyst ratings and target prices for our watchlist - IPO Calendar: Upcoming initial public offerings and market debuts

Watchlist Stocks: AAPL, MSFT, GOOGL, AMZN, NVDA, META, TSLA, AVGO, TSM

This report is generated using advanced AI research capabilities with real-time market data access.

Gold ETFs (GLD, IAU, BAR): Institutional Outlook as of February 12, 2026

Trading Idea: Buy Rationale (TL;DR): Most top research houses remain structurally bullish on gold into 2H26–FY26 on persistent central-bank buying, rising private‑sector diversification into bullion/ETFs, and prospects for lower real rates—supporting continued upside for broad gold ETF exposure (GLD, IAU, BAR). (moneycontrol.com)

Gold set successive record highs through late 2025 and early 2026, with elevated two‑way volatility after the January 30, 2026 policy headlines around the next Fed chair; nevertheless, banks cite sticky official‑sector demand and renewed ETF inflows as intact pillars for prices this year. (barrons.com)

Key Drivers - Official‑sector (central bank) accumulation and EM reserve diversification. - Private‑sector diversification into gold as a strategic hedge; resumption of ETF inflows. - Prospect of further Fed easing/lower real yields reducing the opportunity cost of holding gold. - Geopolitical and policy uncertainty (tariffs, fiscal trajectory, Fed policy credibility) sustaining safe‑haven demand. - Constrained mine supply response vs. demand-led price dynamics.

Risk Considerations - Faster‑than‑expected Fed tightening or a sharp rise in real yields strengthening the USD. - A material slowdown or reversal in central‑bank purchases. - Large speculative deleveraging (e.g., tighter margins) leading to ETF outflows and price air‑pockets. - Rapid easing in geopolitical tensions and policy uncertainty reducing hedge demand. - Liquidity dislocations in key trading hubs (e.g., China) amplifying short‑term downside volatility.

Given broadly higher 2026 targets (with dispersion across houses), we favor maintaining/adding core gold ETF exposure (GLD, IAU, BAR) on dips, with an eye on real yields, Fed path, and central‑bank purchase trends as the primary watchpoints. (moneycontrol.com)

Stock Ratings

Error retrieving stock ratings information: Connection error.

IPO Calendar

Timeframe: February 12, 2026 to March 12, 2026 (US). Assumes a rolling 30-day window starting today (February 12, 2026).

Near-term US IPO activity features a mix of energy infrastructure and financials. Two operating-company IPOs are firmly on the US calendar for the next two trading days (ARKO Petroleum and Clear Street), while calendars show no additional US IPOs scheduled beyond next week because dates are typically set only 7–10 days in advance. Early‑February pricings set the tone: SOLV Energy priced at $25 and traded up over 20% on debut, while Brazil’s AGI (Agibank) downsized its deal and priced at the low end, underscoring investor selectivity. A sizable Q1 pipeline remains (e.g., Zelis Healthcare), but most lack announced dates as of February 12, 2026. (renaissancecapital.com)

ARKO Petroleum Corp. (APC)

• Expected listing date: 2026-02-12
• Price range: $18.00 (priced)
• Shares offered: 11,111,111 Class A shares (primary); underwriters’ 30‑day option for up to 1,666,666 additional shares.
• Exchange: Nasdaq Capital Market
• Lead underwriters: UBS Investment Bank, Raymond James, Stifel, Mizuho, Capital One Securities
• Business summary: Growth‑oriented wholesale fuel distributor serving ARKO-operated retail sites and third‑party dealers across 30+ US states; newly formed subsidiary carve‑out of ARKO Corp. focused on fee‑based distribution and related fuel operations. (investing.com)
• Notes: Priced at $18 on February 11, 2026; first trade expected February 12, 2026; closing expected February 13, 2026, subject to customary conditions. ARKO Corp. will retain about 75.9% economic interest and 94.0% voting power post‑IPO (subject to greenshoe). Terms include standard 30‑day over‑allotment option. (arkocorp.com)
• Sources: Company press release (Feb 11, 2026), SEC registration (Form S-1/A, Feb 3, 2026), Reuters/Investing.com coverage (Feb 11, 2026)

Clear Street Group Inc. (CLRS)

• Expected listing date: 2026-02-13 (expected)
• Price range: $40.00 – $44.00 (marketing range)
• Shares offered: 23,809,524 Class A shares (primary); 30‑day option for up to 3,571,428 additional shares.
• Exchange: Nasdaq Global Select Market
• Lead underwriters: Goldman Sachs & Co. LLC, BofA Securities, Morgan Stanley, UBS Investment Bank, Clear Street LLC
• Business summary: Financial infrastructure technology company building a cloud‑native, end‑to‑end capital markets platform (including prime brokerage) that unifies trading, risk management, and financing on a single real‑time ledger. (sec.gov)
• Notes: Expected to price February 12 and begin trading February 13, 2026, subject to market conditions. Preliminary prospectus indicates (i) non‑binding cornerstone interest of up to $200 million from funds managed by BlackRock, (ii) a directed share program reserving up to 1,190,476 shares, (iii) dual‑class structure with Clear Street Global Corp. retaining about 88.28% voting power post‑IPO; the company will be a “controlled company” under Nasdaq rules. (sec.gov)
• Sources: SEC Form S‑1/A (Amend. No. 3, filed Feb 10, 2026)

Zelis Healthcare

• Lead underwriters: Goldman Sachs & Co. LLC, JPMorgan Chase & Co.
• Business summary: Profitable healthcare payments platform that facilitates medical claims adjudication and electronic payments between payers and providers; serves 750+ payer clients. (businessinsider.com)
• Notes: Company has confidentially filed for an IPO targeting early 2026; exact timing, exchange, ticker, share count, and price terms were not announced as of February 12, 2026. Media reports indicate Goldman Sachs and JPMorgan as lead banks; plans remain subject to market conditions. (businessinsider.com)
• Sources: Business Insider (Oct 3, 2025), Axios Pro (Oct 3, 2025)

Dates, tickers, ranges, share counts, and underwriter lineups may shift quickly with market conditions and SEC effectiveness. Public calendars beyond roughly 7–10 days are typically blank even when the pipeline is active; treat unscheduled entries as indicative only. If you prefer a different window (e.g., the full month of March 2026), I can re-scope accordingly. (renaissancecapital.com)

Sources

• IPO Calendar: https://www.arkocorp.com/news-events/press-releases/detail/198/arko-corp-and-arko-petroleum-corp-announce-pricing-of?utm_source=openai, https://www.businessinsider.com/zelis-healthcare-hires-goldman-sachs-jpmorgan-early-2026-ipo-2025-10?utm_source=openai, https://www.investing.com/news/stock-market-news/arko-petroleum-prices-ipo-at-18-per-share-to-list-on-nasdaq-432SI-4501583?utm_source=openai, https://www.renaissancecapital.com/IPO-Center/Calendar?utm_source=openai, https://www.sec.gov/Archives/edgar/data/1881567/000119312526043602/d39893ds1a.htm

Disclaimer

This research report is for informational purposes only and does not constitute investment advice. All information is sourced from publicly available data and should be verified independently. Past performance does not guarantee future results.

Generated on: 2026-02-12 at 11:38 UTC
Source: Alpha Signal Monitor - Automated Research System
Contact: For questions about this report, please contact your Alpha Signal Monitor administrator.

Powered by Alpha Signal Monitor | Market Intelligence Through AI